189 related articles for article (PubMed ID: 24980707)
1. FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure.
Montaño M; Sansores RH; Becerril C; Cisneros J; González-Avila G; Sommer B; Ochoa L; Herrera I; Ramírez-Venegas A; Ramos C
Respir Res; 2014 Jun; 15(1):74. PubMed ID: 24980707
[TBL] [Abstract][Full Text] [Related]
2. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.
Olloquequi J; Jaime S; Parra V; Cornejo-Córdova E; Valdivia G; Agustí À; Silva O R
Respir Res; 2018 Jan; 19(1):13. PubMed ID: 29347936
[TBL] [Abstract][Full Text] [Related]
6. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A
Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664
[TBL] [Abstract][Full Text] [Related]
7. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
[TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.
Koo HK; Hong Y; Lim MN; Yim JJ; Kim WJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():1129-37. PubMed ID: 27313452
[TBL] [Abstract][Full Text] [Related]
9. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
Kang MJ; Oh YM; Lee JC; Kim DG; Park MJ; Lee MG; Hyun IG; Han SK; Shim YS; Jung KS
J Korean Med Sci; 2003 Dec; 18(6):821-7. PubMed ID: 14676438
[TBL] [Abstract][Full Text] [Related]
10. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
11. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Beeh KM; Beier J; Kornmann O; Buhl R
Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort.
Linder R; Rönmark E; Pourazar J; Behndig AF; Blomberg A; Lindberg A
Respir Res; 2018 Apr; 19(1):64. PubMed ID: 29650051
[TBL] [Abstract][Full Text] [Related]
13. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity.
Uysal P; Uzun H
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781876
[TBL] [Abstract][Full Text] [Related]
15. MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population.
Bchir S; Ben Nasr H; Garrouch A; Ben Anes A; Abbassi A; Tabka Z; Chahed K
J Gene Med; 2018 Jan; 20(1):. PubMed ID: 29165854
[TBL] [Abstract][Full Text] [Related]
16. Matrix Metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking.
Kraen M; Frantz S; Nihlén U; Engström G; Löfdahl CG; Wollmer P; Dencker M
PLoS One; 2019; 14(2):e0211987. PubMed ID: 30789935
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
Hao W; Li M; Zhang C; Zhang Y; Wang P
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512
[No Abstract] [Full Text] [Related]
18. Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.
Omachi TA; Eisner MD; Rames A; Markovtsova L; Blanc PD
Respir Res; 2011 Mar; 12(1):35. PubMed ID: 21429222
[TBL] [Abstract][Full Text] [Related]
19. [Effects of shuxuening injection on the levels of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in acute exacerbated chronic obstructive pulmonary disease patients].
Wang TJ; Xie ZH; Zhao ZZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):191-4. PubMed ID: 22574591
[TBL] [Abstract][Full Text] [Related]
20. Sputum Biomarkers in Wood and Tobacco Smoke Etiotypes of Chronic Obstructive Pulmonary Disease.
Giraldo-Montoya ÁM; Torres-Duque CA; Giraldo-Cadavid LF; Laucho-Contreras ME; González-Flórez A; Santos AM; Tuta-Quintero EA; Celli BR; González-García M
Int J Chron Obstruct Pulmon Dis; 2024; 19():1-10. PubMed ID: 38179428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
